Key Takeaways
- • University of Manchester launches £10m Founders Fund to provide early-stage capital to student, staff, alumni, and university-affiliated ventures, with individual investment tickets ranging from £25,000 to £250,000.
- • Dr Kevin Lomax, technology entrepreneur and Manchester alumnus, commits £1m philanthropic gift to the fund; the university itself contributes £2m, leaving approximately £7m to be raised from additional donors.
- • Lomax, who founded and led Misys plc to FTSE 100 status, frames the initiative as essential to retaining talent in Manchester and positioning the city as a hub for innovation and business creation.
- • The fund targets high-potential early-stage ventures with explicit focus on supporting entrepreneurship within the university ecosystem and spinning out academic intellectual property into commercial enterprises.
Summary
The University of Manchester has established a £10m Founders Fund designed to catalyze early-stage investment in ventures launched by students, staff, alumni, and university-affiliated entrepreneurs. The initiative represents a structured commitment to commercializing research and retaining entrepreneurial talent within the Manchester region. Individual investments from the fund will range from £25,000 to £250,000 per venture, positioning it as a seed-to-early-growth stage capital source rather than a venture-scale fund.
The fund has secured commitments totaling £3m to date: £2m from the University of Manchester itself and £1m from alumnus Dr Kevin Lomax, a technology entrepreneur with significant track record in scaling software businesses. Lomax, who founded Misys and built it into a FTSE 100-listed company, articulated the strategic rationale for his contribution: "I want to see Manchester as the real heartbeat of the UK, somewhere where innovative ideas are coming from and businesses are emerging. I want Manchester to be a place where talented people don't simply come to study, but choose to stay, build businesses, create jobs, and turn ambitious ideas into a reality." This statement reflects a broader concern about brain drain and the competitive positioning of Manchester against other UK innovation hubs.
The remaining £7m of the £10m target remains to be raised through additional philanthropic and institutional commitments. The Founders Fund represents a university-led initiative to bridge the early-stage funding gap that often constrains academic spin-outs and student-founded ventures, while simultaneously anchoring entrepreneurial talent to the Manchester ecosystem. The fund's structure—targeting university-affiliated ventures specifically—suggests a deliberate strategy to maximize technology transfer from academic research into commercial application.
The fund has secured commitments totaling £3m to date: £2m from the University of Manchester itself and £1m from alumnus Dr Kevin Lomax, a technology entrepreneur with significant track record in scaling software businesses. Lomax, who founded Misys and built it into a FTSE 100-listed company, articulated the strategic rationale for his contribution: "I want to see Manchester as the real heartbeat of the UK, somewhere where innovative ideas are coming from and businesses are emerging. I want Manchester to be a place where talented people don't simply come to study, but choose to stay, build businesses, create jobs, and turn ambitious ideas into a reality." This statement reflects a broader concern about brain drain and the competitive positioning of Manchester against other UK innovation hubs.
The remaining £7m of the £10m target remains to be raised through additional philanthropic and institutional commitments. The Founders Fund represents a university-led initiative to bridge the early-stage funding gap that often constrains academic spin-outs and student-founded ventures, while simultaneously anchoring entrepreneurial talent to the Manchester ecosystem. The fund's structure—targeting university-affiliated ventures specifically—suggests a deliberate strategy to maximize technology transfer from academic research into commercial application.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.